Updated on 31/10/2024
Funding monitored € 4,152,783.23 of which cohesion funds € 2,052,509.78
Given name Amount
European Union2052509.78
Another public source2100273.45
Other resources - Private:
€ 4,978,841
Payments monitored € 681,070.11 of which cohesion funds € 397,957.65
Year Amount Cumulative amount Percentage on public financing
2024681070.11681070.1116

State of progress

Open
Expected start: 03/01/2022
Effective start: 03/01/2022
Expected end: 02/01/2025
Effective end: not available

Type

Theme

Territory

Entities

Planning body
MIMIT MINISTERO DELLE IMPRESE E DEL MADE IN ITALY
Implementing body
BIOPHARMA S.R.L.
Beneficiary
BIOPHARMA S.R.L.
Executor
BIOPHARMA S.R.L.

Programming area

European Regional Development Fund (ERDF)
2014-2020 EU Structural Funds
Programme
NOP ERDF ENTERPRISES AND COMPETITIVENESS
Axis
Promuovere il superamento degli effetti della crisi nel cont
Specific objective
Incremento dell'attività di innovazione delle imprese

Other projects in territory